Glenmark Pharmaceuticals (Glenmark)

Glenmark Pharmaceuticals is the international integrated pharmaceutical company at the heart of which activity – scientific research and development of the innovation medicines.

Business in Russia

2018

As of November, 2018 the largest branch of the company is located in Russia; other key markets of the region are Ukraine, Uzbekistan and Kazakhstan. In this region of Glenmark works in such areas as dermatology, pulmonology, treatment of respiratory diseases, gynecology and gastroenterology.

2006

In April, 2006 Glenmark founded home subsidiary company in Russia, Glenmark Impeks, and began to perform a business activity, import of medicines, sales, distribution and marketing. The company has the warehouse of a class A in the Moscow region, and products are sold to all main national distributors in Russia. In this region more than 35 medicine are sold.

The 1980th

The Glenmark company began activity in the pharmaceutical market of Russia in the mid-eighties after the company was selected from quality of the supplier of medicines for Russia according to the results of the state tender.

History

2011

As of September, 2011 the Glenmark company is provided in eighty countries of the world, including Russia, the USA, India, EU countries, Japan, with the headquarters to Mumbai.

The priority directions of development of the company are further investments and development of research base of the company, development and an output to the world market of new original medicines.

1977

The Glenmark company was founded in 1977.